Large-scale analysis found scientific support for medical cannabis in cancer treatment far outweighs opposition | Research

The takeaway

Across more than 10,000 papers and nearly 40,000 data points, support for medical cannabis in cancer contexts was 31 times stronger than opposition.

Oncologists, medical cannabis researchers, policy advocates

Support for medical cannabis in cancer was 31.38x stronger than opposition across 39,767 data points

What the researchers found

Aggregated analysis showed support for medical cannabis was 31.38x stronger than opposition across health metrics, cancer treatments, and cancer dynamics; anti-inflammatory potential and symptom management were key themes.

Why it matters

Cannabis remains Schedule I in the US, complicating cancer research, yet this analysis suggests overwhelming scientific consensus already supports its therapeutic role in oncology.

The numbers in context

Over 10,000 papers analyzed; 39,767 data points; support was 31.38x stronger than opposition across all cancer topics.

How the study worked

Synthesized data from over 10,000 peer-reviewed papers encompassing 39,767 data points; used sentiment analysis to identify correlations between cannabis use and supported/not-supported/unclear outcomes across cancer categories; sensitivity analysis validated findings.

What this study cannot tell us

Sentiment analysis of papers is an indirect measure of efficacy; publication bias may inflate positive findings; aggregating heterogeneous studies risks oversimplification; does not replace clinical trial evidence.

How to read the evidence

Massive scope but relies on sentiment analysis rather than pooled effect sizes; useful as a consensus indicator but not a substitute for specific clinical evidence.

When this study was published

Published 2025

The bigger picture

The gap between scientific evidence supporting medical cannabis in cancer care and its regulatory classification continues to widen.

Questions still open

Does aggregated sentiment translate to clinical effectiveness? Which specific cancer types show the strongest evidence? What clinical trials are most urgently needed?

Common questions

How strong was the evidence supporting cannabis for cancer?

Across all cancer-related topics analyzed, support for medical cannabis was 31.38 times stronger than opposition.

What were the main supported uses?

Anti-inflammatory properties, management of cancer symptoms (pain, nausea, appetite loss), and emerging evidence for direct anticarcinogenic effects.

Read the original research

Meta-analysis of medical cannabis outcomes and associations with cancer.

Frontiers in oncology, 15, 1490621

View on PubMed ↗Publisher’s paper ↗

Citation

Castle, Ryan D; Marzolf, James; Morris, Miranda; Bushell, William C. (2025). Meta-analysis of medical cannabis outcomes and associations with cancer.. Frontiers in oncology, 15, 1490621. https://doi.org/10.3389/fonc.2025.1490621